Published in J Antimicrob Chemother on February 06, 2008
Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A (2011) 2.75
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov (2013) 1.82
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer (2011) 1.58
Microbial persistence and the road to drug resistance. Cell Host Microbe (2013) 1.37
Growth in a biofilm induces a hyperinfectious phenotype in Vibrio cholerae. Infect Immun (2010) 1.35
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother (2014) 1.13
Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One (2010) 1.13
Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS One (2009) 1.11
Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis (2015) 1.09
In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother (2012) 1.06
Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. Pathogens (2014) 1.05
Increased mutability of Staphylococci in biofilms as a consequence of oxidative stress. PLoS One (2012) 1.03
Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS response. J Antimicrob Chemother (2009) 0.96
Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2012) 0.92
Innovative strategies to overcome biofilm resistance. Biomed Res Int (2012) 0.91
Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. Antimicrob Agents Chemother (2011) 0.90
Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium. BMC Microbiol (2013) 0.90
Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int J Mol Sci (2011) 0.87
Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. PLoS One (2011) 0.87
Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator. Pathog Dis (2015) 0.86
Interspecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms. ISME J (2014) 0.85
Experimental evolution in biofilm populations. FEMS Microbiol Rev (2016) 0.84
Stress relaxation analysis facilitates a quantitative approach towards antimicrobial penetration into biofilms. PLoS One (2013) 0.82
Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence. PLoS One (2013) 0.81
Increased emergence of fluoroquinolone-resistant Campylobacter jejuni in biofilm. Antimicrob Agents Chemother (2013) 0.81
Iron triggers λSo prophage induction and release of extracellular DNA in Shewanella oneidensis MR-1 biofilms. Appl Environ Microbiol (2014) 0.81
The Complex Relationship between Virulence and Antibiotic Resistance. Genes (Basel) (2017) 0.79
Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients. Clin Microbiol Rev (2014) 0.79
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front Cell Infect Microbiol (2017) 0.76
Scaffold-based anti-infection strategies in bone repair. Ann Biomed Eng (2014) 0.75
Control of Biofilm Formation: Antibiotics and Beyond. Appl Environ Microbiol (2016) 0.75
A Genotypic Analysis of Five P. aeruginosa Strains after Biofilm Infection by Phages Targeting Different Cell Surface Receptors. Front Microbiol (2017) 0.75
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature (1990) 5.41
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Validity of accelerometry for the assessment of moderate intensity physical activity in the field. Med Sci Sports Exerc (2000) 4.60
Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell (1990) 3.65
Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization. J Cell Biol (1990) 3.24
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
Hemolysis by asbestos. Environ Res (1971) 2.41
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
Retroviral diversity and distribution in vertebrates. J Virol (1998) 2.22
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Towards MRI guided surgical manipulator. Med Sci Monit (2001) 1.97
Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy (1981) 1.96
Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis (1995) 1.96
Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol (1998) 1.93
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr (2001) 1.91
Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol (2004) 1.90
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res (2001) 1.90
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
Evaluation of alternate coupling reagents to replace alpha-naphthyl amine for the detection of nitrate reduction. Microbios (1976) 1.85
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med (1999) 1.83
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC. J Clin Pathol (2000) 1.81
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Monoclonal antibodies against defined epitopes of the human transferrin receptor cytoplasmic tail. Biochim Biophys Acta (1992) 1.76
Investigating fatigue of less than 6 months' duration. Guidelines for family physicians. Can Fam Physician (1999) 1.73
Objective monitoring of physical activity using motion sensors and heart rate. Res Q Exerc Sport (2000) 1.73
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain (1999) 1.67
Extracorporeal shock-wave lithotripsy: one-year experience with the Dornier lithotripter. Eur Urol (1985) 1.66
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
The t complex polypeptide 1 (TCP-1) is associated with the cytoplasmic aspect of Golgi membranes. Cell (1989) 1.52
Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin? Eur J Endocrinol (1996) 1.52
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Some biochemical effects of asbestos on macrophages. Br J Exp Pathol (1972) 1.44
Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1999) 1.44
Localization of the epidermal growth factor (EGF) receptor within the endosome of EGF-stimulated epidermoid carcinoma (A431) cells. J Cell Biol (1986) 1.43
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology (1999) 1.42
Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav (2001) 1.41
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (1986) 1.40
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res (2000) 1.40
Leech therapy for massive scrotal hematoma following percutaneous transluminal angioplasty. J Urol (1997) 1.40
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
["Second opinion centers". Approach for improving the quality of treatment for testicular tumors]. Urologe A (2006) 1.39
Out-of-hospital intravenous cannulation: the perspective of patients treated by London Ambulance Service paramedics. Acad Emerg Med (2000) 1.38
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem (2001) 1.36
The in vivo effects of asbestos on macrophage membrane structure and population characteristics of macrophages: a scanning electron microscope study. J Reticuloendothel Soc (1976) 1.35
Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake. J Cell Sci Suppl (1985) 1.33
O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest (1985) 1.33
Localisation of the protein and glycoprotein components of bovine nasal epithelial desmosomes by immunoelectron microscopy. EMBO J (1987) 1.33
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology (2004) 1.31
Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab (1999) 1.31
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology (1997) 1.30
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Molecular analysis of the argB gene of Aspergillus nidulans. Mol Gen Genet (1986) 1.28
Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry (2004) 1.28
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr (1988) 1.27
Erectile function after anterior urethroplasty. J Urol (2001) 1.26
Desmopressin response of enuretic children. Effects of age and frequency of enuresis. Am J Dis Child (1983) 1.26
The effects of asbestos on macrophages. CRC Crit Rev Toxicol (1978) 1.25
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
PTEN/MMAC1 mutations in prostate cancer. Prostate Cancer Prostatic Dis (2000) 1.24
Measurement of endotracheal tube cuff leak to predict postextubation stridor and need for reintubation. J Am Coll Surg (2000) 1.24
Two distantly positioned PDZ domains mediate multivalent INAD-phospholipase C interactions essential for G protein-coupled signaling. EMBO J (1998) 1.23
Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. FEBS Lett (1997) 1.22
Blastocyst-ET and monozygotic twinning. J Assist Reprod Genet (2000) 1.22
Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol (2005) 1.22
Prostate cancer metastatic to the stomach. Urology (2004) 1.22
HER2 testing in the UK: further update to recommendations. J Clin Pathol (2008) 1.22
The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis. Br J Clin Pharmacol (1998) 1.22
Understanding the genetics of autoimmune disease: two loci that regulate late onset Addison's disease in Portuguese Water Dogs. Int J Immunogenet (2006) 1.21
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
The ileal neobladder. J Urol (1988) 1.19
Financial analysis, personnel planning and organizational requirements for the installation of a kidney lithotripter in a urologic department. Eur Urol (1984) 1.19
Incidence of strabismus in neonates. Am J Ophthalmol (1985) 1.18